Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France
J Bezin, A Pariente, R Lassalle… - European journal of …, 2014 - Springer
Purpose The recommended pharmacotherapy for secondary prevention of acute coronary
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
syndrome (ACS) is long-term treatment with a combination of four therapeutic classes: beta …
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome
J Bezin, RHH Groenwold, MS Ali… - … and drug safety, 2017 - Wiley Online Library
Purpose The secondary prevention treatment for acute coronary syndrome (ACS) is based
on the combined use of drugs from four therapeutic classes (beta‐blockers, antiplatelet …
on the combined use of drugs from four therapeutic classes (beta‐blockers, antiplatelet …
Use of secondary preventive medications after the first attack of acute coronary syndrome
V Salomaa, R Pääkkönen… - European Journal of …, 2007 - academic.oup.com
Background It is not well-known to what extent evidence-based medications, such as β-
blockers, hypolipidemic medications, and angiotensin-converting enzyme inhibitors, are …
blockers, hypolipidemic medications, and angiotensin-converting enzyme inhibitors, are …
Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French …
N Danchin, O Grenier, J Ferrieres, C Cantet… - Heart, 2002 - heart.bmj.com
Background: There is evidence that several classes of drugs are beneficial for secondary
prevention in patients with coronary artery disease. Objective: To compare the use of …
prevention in patients with coronary artery disease. Objective: To compare the use of …
Impact of prior use of four preventive medications on outcomes in patients hospitalized for acute coronary syndrome--results from CPACS-2 Study
M Li, Y Huang, X Du, S Li, J Ji, A Patel, R Gao, Y Wu - PLoS One, 2016 - journals.plos.org
Background It is widely reported that long-term use of four preventive medications
(antiplatelet agents, angiotensin converting enzyme inhibitor/angiotensin receptor blocker …
(antiplatelet agents, angiotensin converting enzyme inhibitor/angiotensin receptor blocker …
Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study
Objective To investigate the single and combined effectiveness of commonly prescribed
secondary preventive medications (post-acute myocardial infarction (AMI)) in reducing …
secondary preventive medications (post-acute myocardial infarction (AMI)) in reducing …
[HTML][HTML] Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database
BACKGROUND: Both French and international guidelines recommend long-term use of
betablockers, antiplatelet drugs, statins, angiotensin-converting enzyme inhibitors or …
betablockers, antiplatelet drugs, statins, angiotensin-converting enzyme inhibitors or …
Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge
HY Lee, CE Cooke, TA Robertson - Journal of Managed Care Pharmacy, 2008 - jmcp.org
BACKGROUND: Acute coronary syndrome includes life-threatening clinical conditions
ranging from unstable angina to non-Q-wave myocardial infarction and Q-wave myocardial …
ranging from unstable angina to non-Q-wave myocardial infarction and Q-wave myocardial …
Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea
HJ Byeon, YM Yang, EJ Choi - Therapeutics and Clinical Risk …, 2016 - Taylor & Francis
Background Acute coronary syndrome (ACS) is a fatal cardiovascular disease caused by
atherosclerotic plaque erosion or rupture and formation of coronary thrombus. The latest …
atherosclerotic plaque erosion or rupture and formation of coronary thrombus. The latest …
Trends in discharge prescriptions for patients hospitalized for acute coronary syndromes in France from 1995 to 2000. Data from the Usik 1995, Prevenir 1, Prevenir 2 …
N Danchin, G Hanania, O Grenier, L Vaur… - … de Cardiologie et D' …, 2003 - europepmc.org
The use of cardiovascular secondary prevention medications in patients with acute coronary
syndromes was compared in 4 sequential observational surveys carried out in France from …
syndromes was compared in 4 sequential observational surveys carried out in France from …